Protara Therapeutics (TARA)

Protara Therapeutics (TARA) Financial Statements


Protara Therapeutics Financial Overview

Protara Therapeutics's market cap is currently ―. The company's EPS TTM is $-5.94; its P/E ratio is -0.29; Protara Therapeutics is scheduled to report earnings on November 2, 2023, and the estimated EPS forecast is $-0.98. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue$ 4.00K-$ 17.00K$ 0.00$ 0.00
Gross Profit$ 4.00K-$ 17.00K--
EBIT$ -11.29M$ -9.04M$ -39.49M$ -7.42M$ -8.19M
EBITDA$ -11.01M$ -8.70M$ -38.97M$ -6.33M$ -8.14M
Net Income Common Stockholders$ -11.29M$ -9.04M$ -38.95M$ -7.69M$ -8.54M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 80.36M$ 86.61M$ 84.37M$ 96.32M$ 98.46M
Total Assets$ 95.14M$ 106.41M$ 113.29M$ 148.59M$ 154.88M
Total Debt$ 5.93M$ 6.16M$ 6.38M$ 6.60M$ 6.82M
Net Debt$ -74.43M$ -80.45M$ -77.99M$ -89.71M$ -91.64M
Total Liabilities$ 9.92M$ 11.64M$ 11.21M$ 9.41M$ 9.43M
Stockholders Equity$ 85.22M$ 94.77M$ 102.08M$ 139.18M$ 145.46M
Cash Flow-
Free Cash Flow$ -9.41M$ -12.89M$ -5.05M$ -5.43M$ -5.14M
Operating Cash Flow$ -9.41M$ -12.89M$ -5.04M$ -5.35M$ -5.12M
Investing Cash Flow$ 22.35M$ 9.86M$ -18.34M$ 19.05M$ 13.50M
Financing Cash Flow-$ -64.00K-$ -18.00K$ 0.00
Currency in USD

Protara Therapeutics Earnings and Revenue History

Protara Therapeutics Debt to Assets

Protara Therapeutics Cash Flow

Protara Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis